CHM review the available safety data for use of epilepsy medicines during pregnancy
The Commission on Human Medicines (CHM) has reviewed the available safety data for epilepsy medicines use during pregnancy. The review confirmed that lamotrigine (Lamictal) and levetiracetam (Keppra) (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - January 7, 2021 Category: Drugs & Pharmacology Source Type: news
Maternal Use of Valproic Acid Linked to ASD, ADHD in Offspring
THURSDAY, Oct. 29, 2020 -- Maternal use of valproic acid, but not lamotrigine, is associated with an increased risk for autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) among children, according to a study published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 29, 2020 Category: Pharmaceuticals Source Type: news
Attention-deficit hyperactivity disorder-associated impulsive aggression treated with lamotrigine - Sablaban IM, Sivananthan M.
[Abstract unavailable]
Language: en... (Source: SafetyLit)
Source: SafetyLit - August 13, 2020 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Zydus Cadila gets final nod from USFDA to market generic seizures drug
Zydus Cadila has received final approval from the United States Food and Drug Administration (USFDA) to market Lamotrigine extended-release tablets USP in the strengths of 25 mg, 50 mg, 100 mg, 200 mg, 250 mg, and 300 mg, Zydus Cadila said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 1, 2020 Category: Pharmaceuticals Source Type: news
Man's face 'peels off' after rare condition triggered by his antidepressant
WARNING: GRAPHIC CONTENT. Jonathan Laird, 38, from Greenfield, Indiana, was prescribed lamotrigine tablets in April 2016. Within a month red sores broke out inside his mouth and eyeballs. (Source: the Mail online | Health)
Source: the Mail online | Health - January 14, 2020 Category: Consumer Health News Source Type: news
Taro Pharmaceuticals U.S.A., Inc. Issues Voluntary Nationwide Recall of Lamotrigine Tablets USP, 100 mg, 100 Count Bottles
Taro Pharmaceuticals U.S.A., Inc. ( “Taro” or the “Company”) is voluntarily recalling one (1) lot of Lamotrigine 100 mg Tablets, Lot # 331771 (expiration date June 2021) in 100 count bottles, NDC 51672-4131-1 to the consumer level. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 10, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Lamotrigine in the Prevention of Migraine With Aura Lamotrigine in the Prevention of Migraine With Aura
While the antiepileptic drug lamotrigine is not recommended for the prevention of migraine in general, this review suggests that it may be promising for attacks of migraine with aura.Headache (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 4, 2019 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news
Lamictal XR (Lamotrigine Extended-Release Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 4, 2019 Category: Drugs & Pharmacology Source Type: news
FDA Drug Safety Communication: FDA warns of serious immune system reaction with seizure and mental health medicine lamotrigine (Lamictal)
The Food and Drug Administration (FDA) is warning that the medicine lamotrigine (Lamictal) for seizures and bipolar disorder can cause a rare but very serious reaction that excessively activates the body ’s infection-fighting immune system. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 18, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Rare reaction to a drug for her 'mood swings' left 14-year-old girl with a near-fatal rash
WARNING: GRAPHIC CONTENT Ashley SIlverman, 14, from Los Angeles, California, was prescribed Lamictal in November by a psychiatrist to treat her 'abnormal mood swings'. (Source: the Mail online | Health)
Source: the Mail online | Health - February 13, 2019 Category: Consumer Health News Source Type: news
Podcast: Lamotrigine versus carbamazepine monotherapy (single medication treatment) for epilepsy
Up to 70 million people worldwide have epilepsy and there are many Cochrane Reviews of ways to treat it. These include reviews that work with the original researchers to gather data on everyone who was in their studies, to perform individual participant data meta-analyses. In June 2018, Sarah Nevitt and colleagues from the University of Liverpool in the UK updated one of these reviews, comparing two commonly used drugs, lamotrigine and carbamazepine." Carbamazepine and lamotrigine are both recommended as first-line treatments for people with newly diagnosed focal onset epileptic seizures and as second-line treatments for t...
Source: Cochrane News and Events - December 18, 2018 Category: Information Technology Authors: Muriah Umoquit Source Type: news
